A phase I trial of an antisense inhibitor of hepatitis C virus (ISIS 14803), administered to chronic hepatitis C patients
- Resource Type
- Article
- Source
- In
Journal of Hepatology January 2006 44(1):88-96 - Subject
Viral Hepatitis - Language
- ISSN
- 0168-8278